Prophylaxis of childhood migraine: Topiramate versus Propranolol

Iranian Journal of Child Neurology

Volumn 7, Issue 1, 2013, Pages 9-14

  Tonekaboni, Seyed Hassan ^a   Ghazavi, Ahad ^b   Fayyazi, Afshin ^c   Khajeh, Ali ^d   Taghdiri, Mohammad Mahdi ^a   Gorji, Fatemeh Abdollah ^e   Azarghashb, Eznollah ^e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Children; Migraine; Propranolol; Topiramate

Indexed keywords

PROPRANOLOL; TOPIRAMATE;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRESCRIPTION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 84879758518     PISSN: 17354668     EISSN: 20080700     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ 1994 Sep 24; 309 (6957): 765-9.
2. Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache 1994 Jun; 34 (6): 319-28.
3. Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D. Age- and sex-specific incidence rates of migraine with and without aura. Am J Epidemiol 1991 Nov; 134 (10): 1111-20.
4. Marcos J. Cruz, Ignacio Valencia, Agustín Legido, et al, Efficacy and Tolerability of Topiramate in Pediatric Migraine. Pediatr Neurol 2009; 41: 167-170.
5. Ashrafi MR, Shabanian R, Zamani GR, Mahfelati F. Sodium valproat versus Propranolol in pediatric migraine prophylaxis. Eur J Pediatr Neurol 2005; 9 (5): 333-8.
6. Hershey AD, Winner PK. Pediatric migraine: recognition and treatment. J Am Osteopath Assoc 2005 Apr; 105(4 Supple 2):2S-8S.
7. Lewis DW, Scott D, Rendin V. Treatment of pediatric headache. Expert Opin Pharmacother 2002 Oct; 3(10):1433-42.
8. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment scores in a population-based sample of headache sufferers. Cephalalgia 1999 Mar; 19 (2): 107-14.
9. Hershey AD, Powers SW, Vockell ALB, LeCates SL, Kabbouche MA, Maynard MK. PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology 2001 Dec; 57(11): 2034-9.
10. Hershey AD, Powers SW, Vockell ALB, LeCates SL, Segers A, Kabbouche MA. Development of a patientbased grading scale for PedMIDAS. Cephalalgia 2004 Oct; 24 (10): 844-9.
11. Ferraro D, Di Trapani G. Topiramate in the prevention of pediatric migraine: literature review. J Headache Pain 2008 Jun; 9 (3): 147-50.
12. J W. Lance and P J. Goadsby. Mechanism and Management of Headache. Butterworth-Heinemann; 7th edition, 2004.
13. Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache 1994 Jun; 34(6):319-28.
14. Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J et al. Topiramate for migraine prevention in children: a randomized, double blind. Placebo-controlled trial. Headache 2005 Nov-Dec; 46(10):1504-12.
15. Silberstein SD. Topiramate in migraine prevention. Headache 2005 Apr; 45 Supple 1: S57-S65.
16. Gode S, Celebisoy N, Kirazli T, Akyuz A, Bilgen C, Karapolat H et al. Clinical assessment of Topiramate therapy in patients with migrainous vertigo. Headache 2010 Jan; 50(1): 77-84.